Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Ader

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Therapie|January 2, 2022
Health crisis: What opportunities for clinical drug research?Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Therapie|December 20, 2021
Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Viruses|November 14, 2020
Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation RecipientsWilliam Mouton, Anne Conrad, Antonin Bal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2023
New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual MeetingAlexandra Serris, Julien Coussement, Benoît Pilmis, et al.
The Lancet. Infectious Diseases|September 17, 2021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Maude Bouscambert-Duchamp, Maya Hites, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 23, 2022
Mycobacterium tuberculosis genetic features associated with pulmonary tuberculosis severityCharlotte Genestet, Guislaine Refrégier, Elisabeth Hodille, et al.
Scientific Reports|June 25, 2026
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosisNicolas Gendron, Carla Rial, Clément R Massonnaud, et al.
The Journal of Infection|November 1, 2015
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patternsAdrien Quintela, Vanessa Escuret, Sandrine Roux, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa StudyBenjamin Gaborit, Eric Dailly, Bernard Vanhove, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Therapie|January 2, 2022
Health crisis: What opportunities for clinical drug research?Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Therapie|December 20, 2021
Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Viruses|November 14, 2020
Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation RecipientsWilliam Mouton, Anne Conrad, Antonin Bal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2023
New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual MeetingAlexandra Serris, Julien Coussement, Benoît Pilmis, et al.
The Lancet. Infectious Diseases|September 17, 2021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Maude Bouscambert-Duchamp, Maya Hites, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 23, 2022
Mycobacterium tuberculosis genetic features associated with pulmonary tuberculosis severityCharlotte Genestet, Guislaine Refrégier, Elisabeth Hodille, et al.
Scientific Reports|June 25, 2026
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosisNicolas Gendron, Carla Rial, Clément R Massonnaud, et al.
The Journal of Infection|November 1, 2015
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patternsAdrien Quintela, Vanessa Escuret, Sandrine Roux, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa StudyBenjamin Gaborit, Eric Dailly, Bernard Vanhove, et al.
Pageof 17